45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,445
Insurances with rates
16
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| IMPL005358 | IMPLANTABLE/INSERTABLE DEVICE, NOT OTHERWISE CLASSIFIED | $26,810 | $26,810 | — | — | 14 |
| MBLA04300 | AMBULANCE SERVICE, CONVENTIONAL AIR SERVICES, TRANSPORT, ONE WAY (FIXED WING) | $17,044 | $17,044 | — | — | 14 |
| IMP99408 | GENERATOR, NEUROSTIMULATOR (IMPLANTABLE), NON-RECHARGEABLE | $17,010 | $17,010 | — | — | 14 |
| 3006005 | INJECTION, RISANKIZUMAB-RZAA, INTRAVENOUS, 1 MG | $16,349 | $16,349 | — | — | 14 |
| 3005841 | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ | $15,712 | $15,712 | — | — | 14 |
| IMPL005398 | CONNECTIVE TISSUE, HUMAN (INCLUDES FASCIA LATA) | $14,985 | $14,985 | — | — | 14 |
| 3005989 | INJECTION, TENECTEPLASE, 1 MG | $14,939 | $14,939 | — | — | 14 |
| 3002714 | INJECTION, NATALIZUMAB, 1 MG | $13,440 | $13,440 | — | — | 14 |
| 3005769 | INJECTION, NIVOLUMAB, 1 MG | $12,027 | $12,027 | — | — | 14 |
| IMPL005478 | CONNECTIVE TISSUE, HUMAN (INCLUDES FASCIA LATA) | $11,985 | $11,985 | — | — | 14 |
| IMPL005239 | JOINT DEVICE (IMPLANTABLE) | $11,850 | $11,850 | — | — | 14 |
| IMPL005240 | JOINT DEVICE (IMPLANTABLE) | $11,850 | $11,850 | — | — | 14 |
| EDM234500 | Reattachment of shoulder joint capsule without bone transfer | $10,908 | $10,908 | — | — | 14 |
| EDM273800 | Primary suture of tendon below knee | $10,908 | $10,908 | — | — | 14 |
| 3003716 | INJECTION, TENECTEPLASE, 1 MG | $10,556 | $10,556 | — | — | 14 |
| 3003012 | INJECTION, PERTUZUMAB, 1 MG | $9,959 | $9,959 | — | — | 14 |
| IMPL005360 | JOINT DEVICE (IMPLANTABLE) | $9,270 | $9,270 | — | — | 14 |
| 3005721 | INJECTION, PEMBROLIZUMAB, 1 MG | $8,852 | $8,852 | — | — | 14 |
| IMPL005399 | CONNECTIVE TISSUE, HUMAN (INCLUDES FASCIA LATA) | $8,835 | $8,835 | — | — | 14 |
| IMPL005390 | JOINT DEVICE (IMPLANTABLE) | $8,808 | $8,808 | — | — | 14 |
| SUR360050 | OPERATING ROOM SERVICES - GENERAL CLASSIFICATION | $8,600 | $8,600 | — | — | 14 |
| 3003103 | INJECTION, RITUXIMAB, 10 MG | $8,458 | $8,458 | — | — | 14 |
| IMPL005206 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $8,000 | $8,000 | — | — | 14 |
| IMPL005359 | IMPLANTABLE/INSERTABLE DEVICE, NOT OTHERWISE CLASSIFIED | $7,974 | $7,974 | — | — | 14 |
| 3003885 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $7,923 | $7,923 | — | — | 14 |
| IMP99336 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $7,628 | $7,628 | — | — | 14 |
| IMP99337 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $7,628 | $7,628 | — | — | 14 |
| 3005857 | INJECTION, RITUXIMAB-ABBS, BIOSIMILAR, (TRUXIMA), 10 MG | $7,612 | $7,612 | — | — | 14 |
| 3005943 | INJECTION, PEGFILGRASTIM-CBQV (UDENYCA), BIOSIMILAR, 0.5 MG | $7,520 | $7,520 | — | — | 14 |
| 3005970 | INJECTION, PEGFILGRASTIM-CBQV (UDENYCA), BIOSIMILAR, 0.5 MG | $7,520 | $7,520 | — | — | 14 |
| IMP99328 | JOINT DEVICE (IMPLANTABLE) | $7,520 | $7,520 | — | — | 14 |
| PRF274870 | Revision of thigh and lower leg bone components of total knee joint prosthesis | $7,449 | $7,449 | — | — | 15 |
| SUR274870 | Revision of thigh and lower leg bone components of total knee joint prosthesis | $7,449 | $7,449 | — | — | 15 |
| SUR360040 | OPERATING ROOM SERVICES - GENERAL CLASSIFICATION | $7,390 | $7,390 | — | — | 14 |
| 3005968 | INJECTION, RAMUCIRUMAB, 5 MG | $7,358 | $7,358 | — | — | 14 |
| SCL646351 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | $7,312 | $7,312 | — | — | 14 |
| IDM704710 | COMPUTED TOMOGRAPHIC ANGIOGRAPHY (CTA), HEAD AND NECK, WITH CONTRAST MATERIAL(S), INCLUDING NONCONTR | $7,289 | $7,289 | — | — | 14 |
| 3005863 | INJECTION, DURVALUMAB, 10 MG | $7,112 | $7,112 | — | — | 14 |
| IMPL005199 | JOINT DEVICE (IMPLANTABLE) | $6,946 | $6,946 | — | — | 14 |
| 3001124 | INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (NON-ESRD USE) | $6,708 | $6,708 | — | — | 14 |
| 3005979 | INJECTION, ADO-TRASTUZUMAB EMTANSINE, 1 MG | $6,660 | $6,660 | — | — | 14 |
| IMPL005357 | JOINT DEVICE (IMPLANTABLE) | $6,592 | $6,592 | — | — | 14 |
| IMPL005362 | JOINT DEVICE (IMPLANTABLE) | $6,592 | $6,592 | — | — | 14 |
| IMPL005336 | JOINT DEVICE (IMPLANTABLE) | $6,400 | $6,400 | — | — | 14 |
| IMPL005445 | JOINT DEVICE (IMPLANTABLE) | $6,400 | $6,400 | — | — | 14 |
| SUR360030 | OPERATING ROOM SERVICES - GENERAL CLASSIFICATION | $6,159 | $6,159 | — | — | 14 |
| IDM737213 | MRI scan of leg joint without contrast | $6,095 | $6,095 | — | — | 14 |
| CLN595100 | Cesarean delivery with care before and after delivery | $6,087 | $6,087 | — | — | 14 |
| PRF595100 | Cesarean delivery with care before and after delivery | $6,087 | $6,087 | — | — | 15 |
| 3005875 | INJECTION, INCLISIRAN, 1 MG | $6,002 | $6,002 | — | — | 14 |
Showing top 50 of 5,445 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.